HealthTronics Sells Its Orthopaedic ESWL Business for $10.4 Million

HealthTronics' President & CEO, Brad A. Hummel, commented, "Wehave a high degree of confidence in the efficacy of our OrthopaedicESWL technology and its appeal to a large patient population seekingeffective therapy. However, the resources required to fully developthis market would detract from our focused efforts to improve our coreUrology business lines and efficiently integrate and operate it. Thisis a positive outcome for HealthTronics that preserves the emergingOrthopaedic Shockwave industry that we helped build. We are verypleased that the buyer is familiar with the industry, shares ourenthusiasm for its long term future and is prepared to devote the timeand capital necessary to fully develop this opportunity."

Chris Puscasiu, President & CEO of SanuWave, noted: "We areexcited about SanuWave's FDA approved leading orthopedic technologyand the future growth prospects in the therapeutic shock waveindustry. With our motivated staff and strong capital backing, we arenow well-positioned to execute SanuWave's long-term strategy ofbecoming the leading provider of non-urological shockwave treatment."SanuWave is controlled by Prides Capital Partners, LLC.

About HealthTronics, Inc.

HealthTronics provides healthcare services, primarily to theurology community, and manufactures medical devices as well asspecialty vehicles used for the transport of high technology medicaland broadcast & communications equipment. For more information, visitwww.healthtronics.com.

About SanuWave, Inc.

SanuWave, headquartered in Marietta, GA, provides non-invasivesurgical solutions for orthopaedic conditions such as chronic plantarfasciitis and chronic lateral epicondylitis, more commonly known asheel pain and tennis elbow, respectively. For more information, pleasevisit www.sanuwave.com.

About Prides Capital Partners, LLC

Prides Capital, based in Boston, MA and San Francisco, CA,specializes in strategic block, active investing in small- andmicro-cap public and private companies. In partnership with itsmanagement teams, Prides seeks to create value through strategic,operational and financial assistance. For more information visitwww.pridescapital.com.

Statements by HealthTronics' management in this press release thatare not strictly historical, including statements regarding plans,objective and future financial performance, are "forward-looking"statements that are made pursuant to the safe harbor provisions of thePrivate Securities Litigation Reform Act of 1995. AlthoughHealthTronics believes that the expectations reflected in suchforward-looking statements are reasonable, no assurance can be giventhat the expectations will prove to be correct. Factors that couldcause actual results to differ materially from HealthTronics'expectations include, among others, the existence of demand for andacceptance of HealthTronics' services, economic conditions, the impactof competition and pricing, financing efforts and other factorsdescribed from time to time in HealthTronics' periodic filings withthe Securities and Exchange Commission.